MedTrace Logo

Lacrifill for Ocular Surface Optimization in Cataract Surgery

NCT07648095 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2026-08-21

No results posted yet for this study

Summary

This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).

Conditions

  • Cataract

Interventions

DEVICE

Lacrifill Canalicular Filler

Lacrifill Canalicular Filler

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • The Eye Institute of West Florida

    lead OTHER

Principal Investigators

  • Neel Desai, MD · The Eye Institute of West Florida

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-22
Primary Completion
2027-07-15
Completion
2027-07-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07648095 on ClinicalTrials.gov